We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Eribulin induces micronuclei and enhances the nuclear localization of cGAS in triple-negative breast cancer cells.
- Authors
Yamada, Hideyuki; Takada, Mamoru; Ghone, Dhaval; Yu, Muhan; Nagashima, Takeshi; Fujimoto, Hiroshi; Sakakibara, Junta; Hasegawa, Yoshie; Takao, Shintaro; Yamada, Akimitsu; Narui, Kazutaka; Ishikawa, Takashi; Suzuki, Aussie; Otsuka, Masayuki
- Abstract
Eribulin (ERI), clinically utilized for locally advanced or metastatic breast tumors, has shown potential links to the immune system. Notably, the cGAS-STING pathway, a key component of innate immunity, has gained prominence. Yet, limited reports explore ERI's effects on the cGAS-STING pathway. Additionally, the nuclear presence of cGAS remains poorly understood. This study uniquely delves into ERI's impact on both the cytosolic cGAS-STING pathway and nuclear cGAS. ERI enhances nuclear localization of cGAS, resulting in hyper-activation of the cGAS-STING pathway in triple-negative breast cancer cells. Reduction of cGAS heightened both cell proliferation and ERI sensitivity. In clinical data using ERI in a neo-adjuvant setting, patients with low cGAS cases exhibited reduced likelihood of achieving pathological complete response after ERI treatment. These findings illuminate the potential of cGAS and IFNβ as predictive biomarkers for ERI sensitivity, providing valuable insights for personalized breast cancer treatment strategies.
- Subjects
TRIPLE-negative breast cancer; CANCER cells; BREAST; ERIBULIN; NUCLEOLUS; BREAST cancer
- Publication
Scientific Reports, 2024, Vol 14, Issue 1, p1
- ISSN
2045-2322
- Publication type
Article
- DOI
10.1038/s41598-024-64651-y